UK Biotech Sector Shows Signs of Recovery in Q1 2026, Reports BIA
The UK biotech sector is showing signs of recovery, with a 18% increase in equity financing to £552m in Q1 2026 compared to Q4 2025. Venture capital funding also rose by 17%, though the IPO market remains stagnant with no new listings.
Topics: biotech financing IPO activity M&A activity UK market venture capital